These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1725172)

  • 1. Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.
    Kuebler JP; Metch B; Schuller DE; Keppen M; Hynes HE
    Invest New Drugs; 1991 Nov; 9(4):373-4. PubMed ID: 1725172
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study.
    Selby GB; Upchurch C; Townsend J; Eyre HJ
    Cancer Chemother Pharmacol; 1994; 34(2):179-80. PubMed ID: 7514963
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group study.
    Manetta A; Blessing JA; Look KY
    Am J Clin Oncol; 1995 Apr; 18(2):156-7. PubMed ID: 7534978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of a 72-h continuous-infusion schedule of fazarabine.
    Amato R; Ho D; Schmidt S; Krakoff IH; Raber M
    Cancer Chemother Pharmacol; 1992; 30(4):321-4. PubMed ID: 1379523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group study.
    Williamson SK; Crowley JJ; Livingston RB; Panella TJ; Goodwin JW
    Invest New Drugs; 1995; 13(1):67-71. PubMed ID: 7499111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer.
    Ben-Baruch N; Denicoff AM; Goldspiel BR; O'Shaughnessy JA; Cowan KH
    Invest New Drugs; 1993 Feb; 11(1):71-4. PubMed ID: 7688714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of 5-aza-2'-deoxycytidine in advanced ovarian carcinoma. The EORTC Early Clinical Trials Group.
    Sessa C; ten Bokkel Huinink W; Stoter G; Renard J; Cavalli F
    Eur J Cancer; 1990 Feb; 26(2):137-8. PubMed ID: 1691012
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272).
    Surbone A; Ford H; Kelley JA; Ben-Baruch N; Thomas RV; Fine R; Cowan KH
    Cancer Res; 1990 Feb; 50(4):1220-5. PubMed ID: 1688736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of fazarabine (NSC 281272) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Manetta A; Blessing JA; Mann WJ; Smith DM
    Am J Clin Oncol; 1995 Oct; 18(5):439-40. PubMed ID: 7572764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial and pharmacokinetic evaluation of fazarabine in children.
    Heideman RL; Gillespie A; Ford H; Reaman GH; Balis FM; Tan C; Sato J; Ettinger LJ; Packer RJ; Poplack DG
    Cancer Res; 1989 Sep; 49(18):5213-6. PubMed ID: 2475244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aza-2'-deoxycytidine (NSC 127716) in non-seminomatous testicular cancer. Phase II from the EORTC Early Clinical Trials Cooperative Group and Genito-Urinary Group.
    Clavel M; Monfardini S; Fosså S; Smyth J; Renard J; Kaye SB
    Ann Oncol; 1992 May; 3(5):399-400. PubMed ID: 1377488
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer.
    Walters RS; Theriault RL; Holmes FA; Hortobagyi GN; Esparza L
    Invest New Drugs; 1992 Apr; 10(1):43-4. PubMed ID: 1376723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of thioproline in advanced epidermoid head and neck tumors.
    Boccardo F; Barbieri A; Canobbio L; Guarneri D; Merlano M; Rosso R
    Cancer Treat Rep; 1982 Mar; 66(3):585-6. PubMed ID: 7060048
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of gallium nitrate in metastatic or locally recurrent squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Decker DA; Costanzi JJ; McCracken JD; Baker LH
    Cancer Treat Rep; 1984; 68(7-8):1047-8. PubMed ID: 6744339
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase II trial of m-AMSA in head and neck cancer.
    Forastiere AA; Young CW; Wittes RE
    Cancer Chemother Pharmacol; 1981; 6(2):145-6. PubMed ID: 6895486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of fazarabine in advanced colorectal carcinoma.
    Hubbard KP; Daugherty K; Ajani JA; Pazdur R; Levin B; Abbruzzese JL
    Invest New Drugs; 1992 Apr; 10(1):39-42. PubMed ID: 1376722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin, an active drug in advanced head and neck cancer.
    de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
    Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group Study.
    Haas CD; Lehane D; Bottomley R
    Med Pediatr Oncol; 1983; 11(4):281-3. PubMed ID: 6888328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
    Ratanatharathorn V; Drelichman A; Sexon-Porte M; Al-Sarraf M
    Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.